KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Inventory (2016 - 2025)

Resmed (RMD) has disclosed Inventory for 16 consecutive years, with $927.7 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Inventory rose 12.83% year-over-year to $927.7 million, compared with a TTM value of $927.7 million through Jun 2025, up 12.83%, and an annual FY2025 reading of $927.7 million, up 12.83% over the prior year.
  • Inventory was $927.7 million for Q2 2025 at Resmed, up from $862.6 million in the prior quarter.
  • Across five years, Inventory topped out at $1.0 billion in Q1 2023 and bottomed at $457.0 million in Q2 2021.
  • Average Inventory over 5 years is $842.8 million, with a median of $862.6 million recorded in 2025.
  • The sharpest move saw Inventory skyrocketed 62.77% in 2022, then decreased 17.98% in 2024.
  • Year by year, Inventory stood at $457.0 million in 2021, then surged by 62.77% to $743.9 million in 2022, then rose by 25.45% to $933.2 million in 2023, then dropped by 11.89% to $822.2 million in 2024, then grew by 12.83% to $927.7 million in 2025.
  • Business Quant data shows Inventory for RMD at $927.7 million in Q2 2025, $862.6 million in Q1 2025, and $822.2 million in Q2 2024.